TY - JOUR
T1 - Clinical Significance of J Wave in Patients with Brugada Syndrome
AU - Nakano, Makoto
AU - Fukuda, Koji
AU - Wakayama, Yuji
AU - Kondo, Masateru
AU - Yuhi, Hasebe
AU - Al-Sayed Abdel-Shafee, Mohamed
AU - Kawana, Akiko
AU - Shimokawa, Hiroaki
PY - 2011
Y1 - 2011
N2 - Background: Clinical significance of J wave, one of early repolarization characteristics, in Brugada syndrome, remains to be elucidated. In this study, we examined the clinical significance of J wave in clinical symptoms and VF inducibility determined by electrophysiological study in patients with Brugada syndrome. Method and Results: We performed VF induction test in 30 consecutive patients who were suspected as Brugada syndrome with type 1 ECG appearance (male/female, 29/1; averaged age, 48±11[SD] years old). Among the 30 patients, 24 were diagnosed as Brugada syndrome. In these 24 patients, 14 were symptomatic and the remaining 10 were asymptomatic. J wave was observed in 7 out of the 24 patients with Brugada syndrome (29% of Brugada syndrome). In contrast, none of the 6 patients with negative VF induction test had J wave. Moreover, among the 24 patients of Brugada syndrome, J wave was observed in only 1 case out of the asymptomatic 10 cases (10% of asymptomatic Brugada syndrome), whereas it was observed in 6 out of the 14 symptomatic patients (42% of symptomatic Brugada syndrome). Conclusions: These results indicate that J wave could have some clinical implications for both clinical symptoms and VF inducibility in patients with Brugada syndrome, suggesting that J wave reflects the arrhythmogenic substrates and the clinical phenotype in Brugada syndrome.
AB - Background: Clinical significance of J wave, one of early repolarization characteristics, in Brugada syndrome, remains to be elucidated. In this study, we examined the clinical significance of J wave in clinical symptoms and VF inducibility determined by electrophysiological study in patients with Brugada syndrome. Method and Results: We performed VF induction test in 30 consecutive patients who were suspected as Brugada syndrome with type 1 ECG appearance (male/female, 29/1; averaged age, 48±11[SD] years old). Among the 30 patients, 24 were diagnosed as Brugada syndrome. In these 24 patients, 14 were symptomatic and the remaining 10 were asymptomatic. J wave was observed in 7 out of the 24 patients with Brugada syndrome (29% of Brugada syndrome). In contrast, none of the 6 patients with negative VF induction test had J wave. Moreover, among the 24 patients of Brugada syndrome, J wave was observed in only 1 case out of the asymptomatic 10 cases (10% of asymptomatic Brugada syndrome), whereas it was observed in 6 out of the 14 symptomatic patients (42% of symptomatic Brugada syndrome). Conclusions: These results indicate that J wave could have some clinical implications for both clinical symptoms and VF inducibility in patients with Brugada syndrome, suggesting that J wave reflects the arrhythmogenic substrates and the clinical phenotype in Brugada syndrome.
KW - Brugada syndrome
KW - EPS
KW - J wave
UR - http://www.scopus.com/inward/record.url?scp=85009597096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009597096&partnerID=8YFLogxK
U2 - 10.4020/jhrs.27.OP18_3
DO - 10.4020/jhrs.27.OP18_3
M3 - Article
AN - SCOPUS:85009597096
SN - 1880-4276
VL - 27
SP - 210
JO - Journal of Arrhythmia
JF - Journal of Arrhythmia
IS - 4
ER -